Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perou

Showing results (281-290 of 476) with videos related to

Pageof 48
Sort By:
Cancer Research|February 18, 2022
Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic CharacteristicsSonam Bhatia, Melissa Kramer, Suzanne Russo, et al.
Cancer Cell|May 18, 2004
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionChristine H Chung, Joel S Parker, Gamze Karaca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2010
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancerTorsten O Nielsen, Joel S Parker, Samuel Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor modelsGina Song, David B Darr, Charlene M Santos, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2011
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingVessela N Kristensen, Charles J Vaske, Josie Ursini-Siegel, et al.
Cancer Cell|May 30, 2009
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastasesShuying Liu, Makiko Umezu-Goto, Mandi Murph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.
Breast Cancer Research and Treatment|June 21, 2007
Epidemiology of basal-like breast cancerRobert C Millikan, Beth Newman, Chiu-Kit Tse, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBCNatasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.
Pageof 48

Showing results (281-290 of 476) with videos related to

Sort By:
Pageof 48
Cancer Research|February 18, 2022
Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic CharacteristicsSonam Bhatia, Melissa Kramer, Suzanne Russo, et al.
Cancer Cell|May 18, 2004
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionChristine H Chung, Joel S Parker, Gamze Karaca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2010
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancerTorsten O Nielsen, Joel S Parker, Samuel Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor modelsGina Song, David B Darr, Charlene M Santos, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2011
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingVessela N Kristensen, Charles J Vaske, Josie Ursini-Siegel, et al.
Cancer Cell|May 30, 2009
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastasesShuying Liu, Makiko Umezu-Goto, Mandi Murph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.
Breast Cancer Research and Treatment|June 21, 2007
Epidemiology of basal-like breast cancerRobert C Millikan, Beth Newman, Chiu-Kit Tse, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBCNatasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.
Pageof 48